IP Library › Granted Patent US 12,453,583
Granted Patent B2
US 12,453,583 · App. 18/932,397 · Granted Oct 28, 2025

Systems and methods for transport and tissue distraction

Inventors: Emmon Johnny Chen (Aliso Viejo, CA); Shanbao Cheng (Rancho Santa Margarita, CA); Woong Kim (Seattle, WA)
Assignee: BioDynamik, Inc.
A61B17/66A61B2017/00084A61B2017/00221A61B2017/00477A61B2017/564A61B2090/064G16H40/63G16H40/67
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,453,583
App. No.
18/932,397
Granted
Oct 28, 2025
Kind
B2
Abstract

A transport device for increasing biological activity within a patient includes a base including a first end, a second end, an upper surface located between the first end and the second end, and a lower surface located between the first end and the second end, a base anchor configured to statically couple the base to a first portion of a bone of a subject, a translatable anchor configured to engage a growth stimulator, a leadscrew dynamically coupling the base to the translatable anchor, wherein the leadscrew is configured to rotate about a leadscrew axis while substantially maintaining its longitudinal position along the leadscrew axis in relation to the base, such that the growth stimulator, when engaged with the translatable anchor, is capable of independent movement in relation to the base along a stimulation axis that includes at least some transverse displacement with respect to the bone when the base is coupled to the bone via the base anchor, and a screw drive rotatably coupled to the leadscrew and configured to couple to a rotatable mating tool that is configured to rotate the leadscrew via the screw drive.

Claims (46)

1. A transport device for increasing biological activity, comprising:

a base configured to be carried externally to skin of a subject;

two or more base anchors configured to be coupled to the base and configured to statically couple the base to cortex of a bone of a subject;

a translatable interface configured to engage an internal portion of the subject;

a leadscrew dynamically coupling the base to the translatable interface, wherein the leadscrew is configured to rotate about a leadscrew axis while substantially maintaining its longitudinal position along the leadscrew axis in relation to the base, such that the translatable interface is capable of independent movement in relation to the base along the leadscrew axis;

a screw drive rotatably coupled to the leadscrew and configured to couple to a rotatable mating tool that is configured to rotate the leadscrew via the screw drive, wherein the leadscrew is coupled to the base independently from the coupling of the two or more base anchors, and wherein the leadscrew comprises a head having an outer perimeter, the outer perimeter comprising a structural feature; and

an engagement feature carried by the base, wherein physical reaction between the structural feature and the engagement feature when the leadscrew is moved between an engaged position and a disengaged position produces a physical disturbance configured to be sensed by a user via an audible and/or tactile vibration, to provide information to the user related to an extent of relative displacement between the translatable interface and the base.

2. The transport device of claim 1 , wherein the two or more base anchors comprise bone screws configured to pass through skin of the subject.

3. The transport device of claim 1 , wherein the translatable interface comprises one or more translatable bone anchors.

4. The transport device of claim 3 , further comprising:

a translatable platform comprising a female thread configured to be threadingly coupled to a male thread of the leadscrew to enable the translatable platform to be moved in relation to the base via rotation of the leadscrew, wherein the translatable platform is configured to be statically coupled to the one or more translatable bone anchors.

5. The transport device of claim 1 , wherein the translatable interface comprises a plate configured to engage an underside of periosteum covering the bone of the subject.

6. The transport device of claim 5 , further comprising:

a translatable platform comprising a female thread configured to be threadingly coupled to a male thread of the leadscrew to enable the translatable platform to be moved in relation to the base via rotation of the leadscrew, wherein the translatable platform is configured to be statically coupled to the plate.

7. The transport device of claim 1 , wherein the two or more base anchors are each configured to engage the cortex of the bone.

8. The transport device of claim 1 , wherein the two or more base anchors are each configured to threadingly engage the cortex of the bone.

9. The transport device of claim 1 , wherein the leadscrew comprises a threaded shaft.

10. The transport device of claim 9 , wherein the entirety of a threaded shaft of the leadscrew is configured to be maintained between an upper surface and a lower surface of the base.

11. The transport device of claim 1 , wherein the base is configured to be carried adjacent to the skin of the subject.

12. The transport device of claim 1 , wherein the screw drive comprises a non-circular cavity or non-circular protuberance at an end of the leadscrew and configured to remain between a lower surface of the base and a region adjacent to an upper surface of the base.

13. The transport device of claim 1 , wherein a rotational torque required to move the leadscrew from the engaged position to the disengaged position, without any additional external load on the leadscrew, is between about 10 N-mm and about 1000 N-mm.

14. The transport device of claim 1 , wherein the base is configured to be statically coupled to a standard external fixator frame.

15. The transport device of claim 1 , wherein the leadscrew is substantially maintained within physical limits of the base, and further comprising:

a bias abutting one end of the leadscrew to provide at least some longitudinal force against the leadscrew during its rotation.

16. A transport device for increasing biological activity, comprising:

a base configured to be carried externally to and adjacent to skin of a subject;

a first base anchor comprising a first end configured to directly couple to the base and a second end configured to statically couple the base to cortex of a bone of a subject, the first base anchor configured to pass through skin of the subject;

a translatable interface configured to engage tissue of the subject;

a leadscrew dynamically coupling the base to the translatable interface, wherein the leadscrew is configured to rotate about a leadscrew axis while substantially maintaining its longitudinal position along the leadscrew axis in relation to the base, such that the translatable interface is capable of movement in relation to the base along the leadscrew axis;

a screw drive rotatably coupled to the leadscrew and configured to couple to a rotatable mating tool that is configured to rotate the leadscrew via the screw drive, wherein the leadscrew is coupled to the base independently from the coupling of the first base anchor, wherein the leadscrew comprises a head having an outer perimeter, the outer perimeter comprising a structural feature; and

an engagement feature carried by the base, wherein physical reaction between the structural feature and the engagement feature when the leadscrew is moved between an engaged position and a disengaged position produces a physical disturbance configured to be sensed by a user via an audible and/or tactile vibration, to provide information to the user related to an extent of relative displacement between the translatable interface and the base.

17. The transport device of claim 16 , further comprising:

a second base anchor comprising a first end configured to directly couple to the base and a second end configured to statically couple the base to cortex of a bone of a subject, the second base anchor configured to pass through skin of the subject, wherein the leadscrew is coupled to the base independently from the coupling of the second base anchor.

18. The transport device of claim 16 , wherein the translatable interface comprises one or more translatable bone anchors.

19. The transport device of claim 18 , further comprising:

a translatable platform comprising a female thread configured to be threadingly coupled to a male thread of the leadscrew to enable the translatable platform to be moved in relation to the base via rotation of the leadscrew, wherein the translatable platform is configured to be statically coupled to the one or more translatable bone anchors.

20. The transport device of claim 16 , wherein the translatable interface comprises a plate configured to engage an underside of periosteum covering the bone of the subject.

21. The transport device of claim 20 , further comprising:

a translatable platform comprising a female thread configured to be threadingly coupled to a male thread of the leadscrew to enable the translatable platform to be moved in relation to the base via rotation of the leadscrew, wherein the translatable platform is configured to be statically coupled to the plate.

22. The transport device of claim 16 , wherein the first base anchor is configured to engage the cortex of the bone.

23. The transport device of claim 16 , wherein the first base anchor is configured to threadingly engage the cortex of the bone.

24. The transport device of claim 16 , wherein the leadscrew comprises a threaded shaft.

25. The transport device of claim 24 , wherein the entirety of a threaded shaft of the leadscrew is configured to be maintained between an upper surface and a lower surface of the base.

26. The transport device of claim 16 , wherein the base is configured to be statically coupled to a standard external fixator frame.

27. The transport device of claim 16 , wherein the leadscrew is substantially maintained within physical limits of the base, and further comprising:

a bias abutting one end of the leadscrew to provide at least some longitudinal force against the leadscrew during its rotation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2025
From: KIM, WOONG
To: BIODYNAMIK, INC.
Reel/Frame 069929/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 26, 2024
From: CHEN, EMMON JOHNNY; CHENG, SHANBAO
To: BIODYNAMIK, INC.
Reel/Frame 069412/0375 →
Continuity (5)
Provisional Application 63677610 · Jul 31, 2024
Provisional Application 63656900 · Jun 6, 2024
Provisional Application 63554970 · Feb 17, 2024
Provisional Application 63606038 · Dec 4, 2023
Related Publication 20250177007A1 · Jun 5, 2025
References Cited (122)
US 4730608A · Schlein · 1988 [cited by examiner]
US 5180380A · Pursely et al. · 1993 [cited by applicant]
US 5334202A · Carter · 1994 [cited by applicant]
US 5980252A · Samchukov et al. · 1999 [cited by applicant]
US 6171313B1 · Razdolsky et al. · 2001 [cited by applicant]
US 8092463B2 · Fuchs et al. · 2012 [cited by applicant]
US 8419734B2 · Walker et al. · 2013 [cited by applicant]
US 10130405B2 · Skinlo et al. · 2018 [cited by applicant]
US 11925389B2 · Chang et al. · 2024 [cited by applicant]
US 12213708B2 · Cheng et al. · 2025 [cited by applicant]
US 20020165544A1 · Perren et al. · 2002 [cited by applicant]
US 20030104339A1 · Fromovich et al. · 2003 [cited by applicant]
US 20050059864A1 · Fromovich et al. · 2005 [cited by applicant]
US 20050074437A1 · Horvath · 2005 [cited by applicant]
US 20050159754A1 · Odrich · 2005 [cited by applicant]
US 20050159755A1 · Odrich · 2005 [cited by applicant]
US 20050209595A1 · Karmon · 2005 [cited by applicant]
US 20060058785A1 · Fuchs et al. · 2006 [cited by applicant]
US 20090192514A1 · Feinberg et al. · 2009 [cited by applicant]
US 20100266979A1 · Karmon · 2010 [cited by applicant]
US 20110004199A1 · Ross et al. · 2011 [cited by applicant]
US 20120296234A1 · Wilhelm et al. · 2012 [cited by applicant]
US 20140222094A1 · Militz et al. · 2014 [cited by applicant]
US 20140350558A1 · Triplett · 2014 [cited by examiner]
US 20150133937A1 · Benedict · 2015 [cited by applicant]
US 20150223842A1 · Murray et al. · 2015 [cited by applicant]
US 20160151099A1 · Olsen et al. · 2016 [cited by applicant]
US 20170143387A1 · Jansen · 2017 [cited by applicant]
US 20180028231A1 · Singh et al. · 2018 [cited by applicant]
US 20180289855A1 · Abdelkader · 2018 [cited by applicant]
US 20190175231A1 · Forsell · 2019 [cited by applicant]
US 20190290253A1 · Trabish et al. · 2019 [cited by applicant]
US 20210307786A1 · Ross et al. · 2021 [cited by applicant]
US 20210369287A1 · Boffeli et al. · 2021 [cited by applicant]
US 20220022963A1 · Yu et al. · 2022 [cited by applicant]
US 20230255665A1 · Pak et al. · 2023 [cited by applicant]
US 20230398720A1 · Hipwood et al. · 2023 [cited by applicant]
US 20240407807A1 · Ottoboni et al. · 2024 [cited by applicant]
CN 2460057Y · 2001 [cited by applicant]
CN 203183002U · 2013 [cited by applicant]
CN 203873847U · 2014 [cited by applicant]
CN 105167828A · 2015 [cited by applicant]
CN 106108992A · 2016 [cited by applicant]
CN 109907786A · 2019 [cited by applicant]
CN 105286968B · 2019 [cited by applicant]
CN 110200687A · 2019 [cited by applicant]
CN 210056111U · 2020 [cited by applicant]
CN 111053604A · 2020 [cited by applicant]
CN 210277278U · 2020 [cited by applicant]
CN 111529028A · 2020 [cited by examiner]
CN 211433226U · 2020 [cited by applicant]
CN 211433227U · 2020 [cited by applicant]
CN 111973288A · 2020 [cited by applicant]
CN 112972061A · 2021 [cited by applicant]
CN 213430479U · 2021 [cited by applicant]
CN 113081207A · 2021 [cited by applicant]
CN 113729898A · 2021 [cited by applicant]
CN 216257347U · 2022 [cited by applicant]
CN 216754573U · 2022 [cited by applicant]
CN 113262026B · 2023 [cited by applicant]
CN 116965900A · 2023 [cited by applicant]
CN 117243677A · 2023 [cited by applicant]
CN 109907786B · 2024 [cited by applicant]
EP 2990002A1 · 2016 [cited by applicant]
FR 2653006A1 · 1991 [cited by applicant]
WO WO1999025265A1 · 1999 [cited by applicant]
WO WO2013023898A1 · 2013 [cited by applicant]
WO WO2016154356A1 · 2016 [cited by applicant]
WO WO2017134486A1 · 2017 [cited by applicant]
WO WO2020259712A1 · 2020 [cited by applicant]
WO WO2022238303A1 · 2022 [cited by applicant]
WO WO2024032985A1 · 2024 [cited by applicant]
WO WO2024215706A1 · 2024 [cited by applicant]
WO WO2024251823A1 · 2024 [cited by applicant]
CN-111529028-A English-language translation (Year: 2020). [cited by examiner]
“Discovery and Mechanism of the “Twin Open Skylight and Summon Effects” in Tibial Transverse Transport (TTT),” Weiwei Chen et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Transverse Tibia Transport for the treatment of Diabetic forefoot gangrene: First international case report,” Yong Sheng Chen et al., ASAMI-LLRS Beijing Sep. 2024 (2 pages). [cited by applicant]
“Clinical and Biomechanical Study of Modified Tibial Cortex Transverse Transport on the Treatment of Diabetic Foot,” Xiaofang Ding et al., ASAMI-LLRS Beijing Sep. 2024 (2 pages). [cited by applicant]
“Treatment of Diabetic Foot with Traditional Chinese Medicine Decoction Combined with Tibial Transverse Transport,” Xiaohui Gao et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Comparative Study of Tibial Transverse Transport Technique and Free Anterolateral Thigh Perforator Flap for the Repair of Severe Diabetic Foot Ulcers,” Shunan Dong et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“To comparatively assess the therapeutic efficacy and safety of midshaft and proximal tibial bone transposition in treating diabetic foot ulcers,” Haoheng Huang, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Tibial Cortex Transverse Transport (TTT) promotes diabetic foot ulcers (DFU) healing by mobilizing mesenchymal stem cells (MSCs) through the Sdf 1/CXCR4 axis,” Zhaowei Jiang et al., ASAMI-LLRS Beijing Sep. 2024 (2 page… [cited by applicant]
“The role of TH17 cell in accelerating diabetic ulcer repair after TTT surgery,” Jiakang Jin et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Curative effect of llizarov tibial lateral bone transfer technique combined with recombinant human epidermal growth factor in the treatment of diabetic foot,” Jing Liao, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Mechanism Study on Tibial Transverse Transport Facilitating Bone and Vascular Coupling through H-Type Vessels,” Zhanming Lin, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Clinical observation of tibial transverse bone transfer technique in the treatment of diabetic foot,” Jing Liu, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Tibial Cortex Transverse Transport: A Novel Treatment of Large Area of Deep Wounds in the Patient's Lower Extremities,” Xinyu Nie et al., ASAMI-LLRS Beijing Sep. 2024 (2 pages). [cited by applicant]
“Finite Element Analysis Safety of Tibial Cortex Transverse Transport,” Hongjie Su et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Nursing Care of Patients with Diabetic Foot Wound Treated by Tibial Transverse Transport,” Hua Wang et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Treatment of Complications of Tibial Transverse Transport,” Hua Wang et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“The application effect of the OTO whole-process management model in the treatment of diabetic foot patients with transverse tibial bone transfer,” Tian Yan, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Observation on the curative effect of fibula transverse transport technique in the treatment of diabetic foot ulcer,” Zirui Yu, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Tibial cortex transverse transport surgery activates a systemic immune response against infection to promote wound healing in patients with severe type 2 DFUs,” Lin Yu, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Tibial transverse transport for treatment of diabetic foot accompanied with diabetic nephropathy,” dapeng Yu, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Reconstruction of foot microvasculature after transverse tibial bone transport,” Yonghong Zhang et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Lateral Traction of the Tibial Periosteum in the Management of Chronic Ischemic Lower Limb Diseases,” Naxin Zeng et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Clinical analysis of the therapeutic effect of tibial transverse bone transport in the treatment of diabetic foot ulcer,” Dingwei Zhang, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Prognostic Value of IL-6 and Related Cytokines in Angiogenesis Following Transverse Tibial Transplantation for Diabetic Foot Ulcers,” Dingwei Zhang, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“\Clinical experience of transverse tibial displacement in the treatment of ulcers after great saphenous varicose vein surgery,” Yuhua Zhao, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“The association of the perioperative neutrophil-to-lymphocyte ratio with wound healing in patients with Wagner grade 3 and 4 diabetic foot ulcers after tibial cortex transverse transport surgery: A prospective observat… [cited by applicant]
“Simulated finite element analysis of the effect of tibial cortex transverse transport on tibial mechanics in rats,” Puxiang Zhen et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Tibial periosteal distraction in chronic limb threatening ischemia,” Peilin Zhou, ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
“Interventional therapy combined with transverse tibial bone transport for the treatment of severe ischemic ulcer of the lower limbs in elderly patients,” Jieyi Zuo et al., ASAMI-LLRS Beijing Sep. 2024 (1 page). [cited by applicant]
Operaive Technique. LRS Advanced™. Limb Reconstruction, Orthofix Orthopedics. LR-0901-OPT-E0 02/22 (424935) (52 pages) Available on internet Sep. 25, 2024. [cited by applicant]
“Transverse Kallusdistraktion. Neue Chancen für den Extremitätenerhalt?” Thaller PH et al., Unfallchirurg 2022 · 125:282-287 https://doi.org/10.1007/s00113-022-01156-1 Published online Mar. 17, 2022. [cited by applicant]
“Tibial Cortex Transverse Transport Corticotomy: A Case Series on a Novel Approach to Limb Salvage in the Setting of Peripheral Vascular Disease,” Matthew A. Peter et al., Foot & Ankle Surgery: Techniques, Reports & Cas… [cited by applicant]
Bfix External Fixation System. Aike Medical Instrument CO Ltd. (16 pages) Available on internet Sep. 20, 2024. [cited by applicant]
BFIX External Fixator System. ENDO website (1 page) Available on internet Sep. 20, 2024 endo.id/catalog/product/bfix-external-fixator-system. [cited by applicant]
“Periosteal distraction for foot preservation contributes to favorable clinical effects and prognosis in a foot ulcer patient with critical limb ischemia after multiple operations,” Junjun Wang et al., Am J Transl Res 2… [cited by applicant]
“Periosteum distraction for the treatment of diabetic foot ulcer: theoretical basis and clinical verification (Chinese),” Liu Jie et al., Chinese Journal of Tissue Engineering Research, 2095-4344(2022)32—pp. 5236-5241 w… [cited by applicant]
“Analysis of the short-term efficacy of tibial periosteal distraction in the treatment of diabetic foot (Chinese),” Chen et al., Johrnal of Practical Orthopaedics, vol. 28, No. 8, Aug. 2022 (5 pages, in 2 separate pdfs … [cited by applicant]
“Mechanical strain induces ex vivo expansion of periosteum,” Mary M. Walker et al., PLoS One 17(12): e0279519. https://doi.org/10.1371/journal.pone.0279519 Dec. 30, 2022. [cited by applicant]
Periosteum distraction case study (Chinese), Chinese Journal of Clinical Research, Aug. 2023, vol. 36, No. 8, pp. 1264-1266. [cited by applicant]
Maxframe Autostrut™ Multi-Axial Correction System. DePuy Synthes. (4 pages) 2022. [cited by applicant]
“Effect of tibial cortex transverse transport in patients with recalcitrant diabetic foot ulcers: A prospective multicenter cohort study,” Yan Chen et al., Journal of Orthopaedic Translation 36 (2022) pp. 194-204. [cited by applicant]
“Twenty Years Development of Tibial Cortex Transverse Transport Surgery in PR China,” Zheng Liu et al., Orthopedic Surgery (2022) 14: 1034-1048. [cited by applicant]
“Clinical and Mechanistic Study of Transverse Tibial Transport in Complex Foot Ulcers,” Samuel KK Ling reporting, https://www.clinicaltrials.gov/study/NCT05704075?cond=diabetic%20foot%20ulcer&term=tibial% 20transport&ra… [cited by applicant]
“Comparison of the efficacy of tibial transverse transfer and periosteal distraction techniques in the treatment of diabetic foot refractory ulcers,” Yang Yang et al., Frontiers in Surgery, 11:1396897. doi: 10.3389/fsur… [cited by applicant]
“Transverse tibial bone transport for non-healing heel wound: A case report,” Ally A. Yang et al., International Journal of Surgery Case Reports, 124 (2024) https://doi.org/10.1016/j.ijscr.2024.110400. [cited by applicant]
“Transverse Bone Transport for the Treatment of Dysvascular Complex Wounds of the Foot: A Case Series,” Lisa Grant-McDonald et al., Scientific Congress of the American College of Foot and Ankle Surgeons, Feb. 1-2, 2024 … [cited by applicant]
Orthofix Press Release, available on the internet Jan. 25, 2025 (2 pages). [cited by applicant]
PCT International Search Report and Written Opinion for PCT/US2024/058493, Applicant: Biodynamik, Inc., Forms PCT/ISA/220, 210, and 237 dated Apr. 1, 2025 (30 pages). [cited by applicant]